Organ And Tissue Transplantation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Tissue and Organ Transplantation
• Bone Graft Transplantation
• Product Definitions
• Organ Transplantation
• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation
• Pancreas Transplantation
• Small Intestine Transplantation
• Lungs
• Tissue Transplantation
• Corneal Transplantation
• Blood Stem Cell Transplantation
• Bone Marrow Transplantation
• Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. Introduction

2. Market Overview

• Current and Future Analysis
• Demand and Supply Imbalance
• Cardiac Arrest Death Patients - The Untapped Potential Donors
• Transplantation Expenses

3. Market Trends

• Living Donor Organs on the Rise
• Combined Organ Transplantation - Gaining Attention
• Awareness Programs and Education to Address Organ shortage
• Increasing Consent Rates - A Key Factor
• Transplant Tourism - Creating Brighter Avenues
• Alliances to Play a Key Role
• Graying Population and Chronic Diseases Surge Need for Transplants
• Fetal Tissue for Bionic Devices - Assuming Importance

4. Major Issues Impacting Transplantation Market

• Organ Rejection - A Major Barrier to Transplantation
• Scarcity of Donor Organs - A Stumbling Block in Organ Transplantation
• Other Issues for Organ Transplantation
• Ethical Concerns in Transplants
• Bioethical Issues Hindering Organ Donation Process
• Lack of Requisite Expertise - Hindering Implantation Process

5. Product Overview

• Tissue and Organ Transplantation
• Organ Transplantation
• Heart Transplantation
• Heart Diseases and Disorders
• Post Operative Complications and Consequences of Heart Transplants
• Bleeding
• Infection
• Arrythymia
• Heart Attack
• Coronary Artery Disease
• Respiratory Dysfunction
• Renal Dysfunction
• Graft Rejection and Dysfunction
• Death
• Kidney Transplantation
• Kidney Disorders and Diseases
• Donor Evaluation
• Waiting List
• Surgery/Post-Operation
• Post-Operative Supervision and Issues
• Liver Transplantation
• Liver Disorders and Diseases
• Pancreas Transplantation
• Post Operative Complications and Consequences of Pancreas Transplants
• Small Intestine Transplantation
• Intestine Disorders and Diseases
• Heart-and-Lung Transplantation
• Lung Transplantation
• Lung Diseases and Disorders
• Lung Patients Survival Statistics
• Tissue Transplantation
• Types of Grafts
• Autograft
• Allograft / Homograft
• Transplant Tolerance
• Isograft
• Xenograft
• Corneal Transplantation
• Penetrating Keratoplasty
• Lamellar (Non-Penetrating) Keratoplasty
• Aftercare
• Risks Associated with Corneal Transplants
• Transplantation Outcomes
• Morbidity and Mortality Rates
• Alternatives
• Blood Stem Cells
• Peripheral Blood Stem Cell Transplant
• Umbilical Cord Blood Stem Cell Transplant
• Bone Marrow and Hematopoietic Stem Cells
• Bone and Tissue Transplantation
• Bone Marrow Transplants
• Stem Cell Therapy
• Human Heart Valves
• Atrioventricular Valves
• Mitral Valve
• Tricuspid Valve
• Semilunar Valves
• Aortic Valve
• Pulmonic Valve
• Pathology of Valves
• Prosthetic Heart Valves
• Prosthetic Mechanical Valve
• Advantages
• Disadvantages
• Prosthetic Biologic Valve
• Advantages
• Disadvantages
• Fetal Cells
• Fetal Tissue for Transplantation
• Storage Duration Time
• Storage Time Period for Organs and Tissues
• Cold Ischemia Time
• Transplantation Immunology
• Acute Cellular Rejection
• Chronic Rejection
• Post Transplant Observations
• Types of Donors
• Alive Donors
• Related Donors
• Good Samaritans
• Rewarded/Forced Donors
• Deceased Donors
• Directed / Allocated
• Organs and Tissues Transplanted by Type of Donor
• Organ/Tissue Donation and Eligibility Criteria
• Factors Considered for Matching Recipients to Donor Organs
• Testing
• Blood Typing
• Tissue Typing
• Histocompatibility - A Major Barrier for Organ Transplantation
• Transplantation - Safety Requirements
• Waiting List
• Active Waiting List Patients
• Inactive Waiting List Patients
• History
• Major Milestones in Organ Transplantation

6. Artificial Organs

• Artificial Organs Revolutionize Medical Technology Industry
• Artificial Organs
• Categorization of Artificial Organs
• External Artificial Organs
• Internal or Implantable Artificial Devices
• Artificial Heart
• Total Artificial Heart (TAH)
• Ventricle Assist Device (VAD)
• Right Ventricular Assist Systems (RVAS)
• Left Ventricular Assist Systems (LVAS)
• Various Ventricle Assist Devices
• Artificial Kidney (Dialyzer)
• Limitations of Artificial Kidney
• Artificial Liver
• Various Liver Assist Devices
• Categorization of Liver Devices
• Mechanical Systems
• Bio-Artificial Systems
• Artificial Pancreas
• Artificial Lungs (Oxygenator)
• Types of Artificial Lung
• Artificial Cornea
• Keratoprostheses
• Tissue Engineered Corneas
• Artificial Skin/Skin Replacement Products
• AlloDerm Regenerative Tissue Matrix
• Apligraf
• Cymetra Micronized AlloDerm Tissue
• Dermagraft
• Epicel
• Integra Products
• OrCel
• TransCyte
• Core Competitive Factors
• Market Outlook for Artificial Organs

7. Preservation Solutions & Immunosuppressant Drugs

• Organ Preservation Solutions
• Celsior Solution
• Collins Solution
• Euro Collins Solution
• Custodiol® HTK Solution
• Hypothermosol
• ViaSpan
• Immunosuppressant Drugs
• Antibody Products for Treatment of Organ Transplant Rejection
• Antithymocyte Globulin
• ATGAM
• Campath/MabCampath
• Thymoglobulin
• Therapeutic Antibody Products
• Antiproliferative Agents
• Azathioprine
• CellCept
• Certican
• Myfortic
• Calcineurin Inhibitors
• Cyclosporine
• Gengraf
• Neoral
• Pulminiq
• Tacrolimus
• Prograf
• TOR Inhibitors
• Side Effects of Immunosuppression Therapy
• Select Immunosuppressant Drug Players
• Astellas Pharma US, Inc., (USA)
• F.Hoffmann-La Roche Ltd (Switzerland)
  • Novartis AG (Switzerland)
  • Wyeth (USA)

8. Regulatory Environment

• Transplant Center
• Organ Procurement Organization (OPO)
• Health Resources and Services Administration (HRSA)
• Division of Transplantation (DoT)
• United Network for Organ Sharing (UNOS)
• Organ Procurement and Transplantation Network (OPTN)
• University Renal Research and Education Association (URREA)
• Scientific Registry of Transplant Recipients (SRTR)
• Funding Sources
• Patient Education and Advocacy Organizations
• Legal Framework for Transplantation
• Legislation Covering Organ Transplant
• Organ Transplantation and Ethics
• Regulations Governing Artificial Organs

9. Product Development/Innovations

• Pluristem Develops New Cell Graft for Cancer Patients
• CryoLife Develops Cryopreserved Orthopaedic Tissues Implants
• Japanese Innovators Develop New Prognostic Scoring Model for Liver Transplants
• EUREKA project E! 2674 MIDAS Develops New Test to Improve Graft Survival

10. Recent Industry Activity

• St. Jude Medical’s Heart Valve Obtains US FDA Approval
• Zimmer and Tutogen Expand Distribution Partnership
• Leman Cardiovascular Acquires Hancock Jaffe Laboratories
• Nabi Acquires Commercialization Rights of ATG-Fresenius S for North America
• Cytopia and Novartis Ink Research Collaboration and Global License Agreement
• ZLB Behring Inks Agreement with MedImmune
• Japanese Team To Perform Liver Transplants in Hyderabad
• Nabi Bags Approval for HB Intravenous in Liver Transplant Patients
• Schering-Plough Announces PROTECT study Initiation
• Allegheny General Hospital To Establish Adult Liver Transplantation Center in Oakland
• Global Hospitals to Setup an Organ Transplant Center in Kolkata
• GCC to Establish Organ Transplant Center
• Delhi-Based Hospital Offers Help in Setting Up of Liver Transplant Center in Lahore
• Kaiser To Shut Down Kidney Transplant Center
• Abiomed Obtains FDA Approval for Selling Artificial Hearts
• Astellas Bags FDA Approval to Use Prograf in Heart Transplant Patients
• New York State Department of Health Approves Program for Kidney Transplant for Queen’s Community
• National Heart Institute Conducts First Double Lung Transplant in Malaysia
• The Netherlands Obtains Orphan Drug Designations for Treatment of DGF
• Papworth Transplants First Beating Human Heart in the UK
• Enzon to Return ATG-Fresenius S Rights to Fresenius Biotech
• Schering-Plough to Conduct ‘PROTECT’ Study
• Community Tissue Services Selects NOVA 2200 Supercritical Carbon Dioxide Sterilization Technology
• CryoLife Inks Agreement with The Magdi Yacoub Institute to Enhance Xenografts in Human Transplantation
• ReGen Inks Exclusive Marketing Deals with Polymedic and Xmedica
• University of California-Irvine Announces Closure of Liver-Transplantation Program
• Swedish Health Services Bags Approval for Liver Transplant Program
• New Organ Transplant Research Center in South Korea
• Child Lung Transplant Unit to be opened in Melbourne Hospital
• Narayana Hrudayalaya Health City Establishes Exclusive Organ Transplant Hospital
• Liver Transplant Facility in Delhi Region
• First Liver Transplant Research Institute in China
• PIMS to establish Liver Transplant Unit
• Liver Transplant Programme in Pakistan
• Isotechnika Gains FDA Approval
• FDA Offers Approval for Brain Stem Cell Transplant Trial
• Methodist Specialty and Transplant Hospital Gains Approval to Execute Liver Transplants
• Cubist Pharmaceuticals Enters into Licensing Agreement with XTL Biopharmaceuticals
• Jackson Memorial Receives Approval from the U.S. Centers for Medicare and Medicaid Services
• Royal Perth Hospital to Open Lung Transplant Unit in Perth
• Mater Hospital Opens Lung Transplant Unit in Dublin
• Genzyme Makes a Synergistic Purchase of Ilex Oncology
• NIAID Sets Up Clinical Consortium to Enhance Organ Transplants Success
• Chiron files NDA for Pulminiq Inhalation Solution
• Roche Acquires IL-15 Antagonist
• Genzyme Completes Acquisition of SangStat

11. Focus on Select Global Players

• Abiomed Inc (USA)
• Arbios Systems, Inc. (USA)
• CryoLife, Inc.(USA)
• Exactech, Inc. (USA)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• Forticell Bioscience, Inc. (USA)
• Gambro AB (Sweden)
• Genzyme Corporation (USA)
• Jarvik Heart, Inc. (USA)
• LifeCell Corporation (USA)
• Medtronic, Inc. (USA)
• MicroMed Cardiovascular, Inc. (USA)
• Organogenesis, Inc. (USA)
• SynCardia Systems (USA)
• Terumo Corporation (Japan)
• Thoratec Corporation (USA)
• Ventracor Limited (Australia)
• WorldHeart Corporation (USA)

12. Global Market Perspective

• Table 1: World Recent Past, Current & Future Market Analysis for Organ Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 2: World 10-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 3: World Recent Past, Current & Future Market Analysis for Heart Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 5: World Recent Past, Current & Future Market Analysis for Kidney Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 6: World 10-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 7: World Recent Past, Current & Future Market Analysis for Liver Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 8: World 10-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 9: World Recent Past, Current & Future Market Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 10: World 10-Year Perspective for PancreasTransplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 11: World Recent Past, Current & Future Market Analysis for Lung Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 12: World 10-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
• Table 13: World Recent Past, Current & Future Market Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
• Table 14: World 10-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia (including Japan), Latin America and Rest of World Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current and Future Analysis
  • Analysis by Value Sales
  • Liver Transplantation Sustains Dominance
  • Skin Grafts Take the Largest Chunk
  • Analysis by Number of Procedures
  • Intestine - Fastest Growing Segment
  • Skin Grafts - Largest and Fastest GrowingTissue Segment
  • Bone Graft Procedure Volume by Graft Typeand Application
  • US Organ Transplant Facts and Figures
  • Number of Organ Transplants WitnessesPhenomenal Surge-2004
  • Increasing Organ Donations in New Jersey
  • Innovative Means of Organ Procurement to IncreaseOrgan Donations
  • A New Technique to Enhance and Extend KidneyTransplants
  • California Stands Up Against Insurance onHIV Patients’ Transplantation
  • Awareness Programs to Address Shortage ofMinority Donors
  • Organs and Tissues on A Recovery Spree
  • Unexamined Human Tissue Transplants - A MajorThreat
  • Defective Medical Implants - A Health Hazard
  • Eye Infections from Usage of MoistureLoc Leadsto Corneal Transplants
  • Sources of Donor Organs
  • Table 15: US Kidney Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 16: US Liver Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 17: US Heart Donations by Cadaveric Donor Type for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 18: US Lung Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 19: US Pancreas Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 20: US Intestine Donations by Donor Type - Cadaveric and Living for Years 2000 through 2005 (includes corresponding Graph/Chart)
  • Lung Transplantation
  • Lung Transplant Death Rates
  • Heart-Lung Transplantation
  • Incidence of Organ Transplants
  • Table 21: Incidence of Organ Transplant Type for Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung Transplants per 1 Million Population in the US for the Year 2000 through 2005 (includes corresponding Graph/Chart)
  • Table 22: Incidence of Organ Transplants (Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung) per 1 Million Population in the US by Recipient Race (White, African American, Asian, Hispanic, and Other) for 2005 (includes corresponding Graph/Chart)
  • Table 23: Incidence of Organ Transplants (Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung) per 1 Million Population in the US by Recipient Gender (Male, and Female) for 2005 (includes corresponding Graph/Chart)
  • Table 24: Incidence of Organ Transplants (Kidney, Liver, Heart, Lung, Pancreas, Intestine, and Heart-Lung) per 1 Million Population in the US by Recipient Age (65+ Years, 50-64 Years, 35-49 Years, 18-34 Years, 11-17 Years, 6-10 Years, 1-5 Years, <1 Year) for 2005 (includes corresponding Graph/Chart)
  • Waiting List
  • Table 25: Waiting List of Patients As of July 2007 (includes corresponding Graph/Chart)
  • Table 26: Waiting List of Active and Inactive Patients for Years 2004 & 2005 (includes corresponding Graph/Chart)
  • Waiting List for Heart Transplants
  • Table 27: Waiting List of Active Patients for Heart for Years 2000 to 2005 (includes corresponding Graph/Chart)
  • Categorized by Diseases
  • Categorized by Age
  • Categorized by Race
  • Death Rates on Waiting List
  • Kidney Transplantation Waiting List
  • Categorized by Age
  • Categorized by Race
  • Waiting List for Liver Transplants
  • Categorized by Age
  • Categorized by Race
  • Categorized by Gender
  • Categorized by Diseases
  • Categorized by Re-Transplant Necessity
  • Death Rates on Waiting List
  • Pancreas Transplant Waiting List
  • Simultaneous Pancreas Kidney TransplantationWaiting List
  • Pancreas After Kidney and Pancreas TransplantAlone Transplant Waiting List
  • Waiting List for Lung Transplants
  • Categorized by Age
  • Categorized by Primary Diagnoses
  • Categorized by Gender and Ethnic Makeup
  • Waiting Time for Lung Transplant
  • Annual Death Rates
  • Waiting List for Intestine Transplants
  • Death Rates on Waiting List
  • Patient Survival Rate
  • Table 28: Patient Survival Percent by Organ Type for 1-Year and 5-Years (includes corresponding Graph/Chart)
  • Annual Death Rate of Kidney Recipients
  • Pancreas Patient Survival Rate
  • Pancreas Graft Survival Rate
  • Immunosuppression Therapy
  • Immunosuppression Therapy for Heart TransplantRecipients
  • Table 29: Usage Rates of Major Immunosuppressants in 2004 (includes corresponding Graph/Chart)
  • Immunosuppression Therapy for Kidney TransplantRecipients
  • Immunosuppression Therapy for PancreasTransplants
  • Immunosuppression Therapy for Lung TransplantRecipients
  • Table 30: Usage Rates of Induction Therapies in 2005 (includes corresponding Graph/Chart)
  • Immunosuppression Therapy Following BoneMarrow Transplantation
  • Table 31: US Recent Past, Current & Future Market Analysis for Immunosuppressive Drug Therapy Following Bone Marrow Transplantation by Category - For GVHD and Maintenance Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Immunosuppression Therapy Following BloodStem Cell Transplantation
  • Table 32: US Recent Past, Current & Future Market Analysis for Immunosuppressive Drug Therapy Following Blood Stem Cell Transplantation by Category - For GVHD and Maintenance Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • United Network for Organ Sharing
  • The American Association of Tissue Banks(AATB)
  • Accredited Banks from Select US States
  • Eye Banks from Select US States
  • Number of Transplant Center Programs
  • Table 33: Number of Transplant Center Programs for the Years 1990, 1997 and 2000 (includes corresponding Graph/Chart)
  • Table 34: Average Number of Transplants Per Program for the Years 1990, 1997 and 2000 (includes corresponding Graph/Chart)
  • Strategic Developments
  • Select Players
  • Abiomed Inc
  • Arbios Systems Inc.
  • Arrow International, Inc.
  • CryoLife, Inc.
  • Exactech, Inc.
  • Genzyme Corporation
  • Jarvik Heart Inc.
  • LifeCell Corporation
  • Medtronic Inc
  • MicroMed Cardiovascular, Inc.
  • Organogenesis Inc
  • Forticell Bioscience, Inc.
  • SynCardia Systems
  • Thoratec Corporation
  • WorldHeart Corporation
• B. Market Analytics
  • Table 35: US Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 36: US 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 37: US Recent Past, Current & Future Market Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves and Skin Grafts Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 38: US 10-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Dollar Sales for Cornea, Heart Valves and Skin Grafts Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 39: US Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 40: US 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 41: US Recent Past, Current & Future Market Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 42: US 10-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 43: US Recent Past, Current & Future Market Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 44: US 10-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart)
  • Table 45: US Recent Past, Current & Future Market Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 46: US 10-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Current and Future Analysis
  • Canadians More Receptive to Organ Transplants
  • Waiting List
  • Table 47: Canadian Patients (Active and Inactive) on Waiting List by Organ Type for 2005 & 2006 (includes corresponding Graph/Chart)
  • Organ Donation
  • Success Rate of Organ Transplants
  • Table 48: Success Rate of Organ Transplants After 1-Year (includes corresponding Graph/Chart)
  • Strategic Development
• B. Market Analytics
  • Table 49: Canadian Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 50: Canadian 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

3. Europe

• A. Market Analysis
  • Current and Future Analysis
  • Italy
  • Surge in Organ Transplants
  • The United Kingdom
  • Organ and Tissue Transplantation in the UK
  • Table 51: UK Organ Transplantations for the Years 2003 and 2004 (includes corresponding Graph/Chart)
  • Table 52: Waiting List (Active and Inactive) by Organ Type in the UK for the Years 2003 and 2004 (includes corresponding Graph/Chart)
  • Kidney Transplantation
  • Waiting List
  • Categorized by Race
  • Categorized by Age and Sex
  • Donors and Transplantation Recipients
  • Categorized by Race
  • Categorized by Age and Gender
  • Pancreas Transplantation
  • Waiting List
  • Categorized by Race
  • Categorized by Age and Gender
  • Donors and Transplantations
  • Categorized by Race
  • Categorized by Age and Gender
  • Lung Transplant Record Numbers Boasts ofLung Power
  • Bladder Transplantation A Roaring Success
  • Russia
  • Organ Transplantations Show a Downward Trendin Russia
  • Turkey
  • Akdeniz University - A World-RenownedTransplantation Center
  • Strategic Developments
  • Select Players
  • Fresenius Medical Care AG & Co. KGaA(Germany)
  • Gambro AB (Sweden)
• B. Market Analytics
  • Table 53: European Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 54: European 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

4. Asia

• A. Market Analysis
  • Current & Future Analysis
  • Australia
  • Australia Registers Highest Success Rate inTransplantation
  • Kidney Transplantation Snapshots
  • Organ Donor Register
  • China
  • Organ Transplantations in China
  • Transplantation Tourism in China
  • Low Transplant Success Rate Due to UnskilledProfessionals
  • Cost Effective Transplant Procedures Lure ForeignPatients
  • Illegal Activities for Harvesting Organs in China
  • Regulations on Organ Transplantation
  • Regulations on Brain Death
  • India
  • Overview of Renal Transplantation
  • Transplantation Expenses in India
  • Indian Government to amend OrganTransplantation Rules
  • Singapore
  • Awareness Programs to Increase Living KidneyDonations in Singapore
  • Taiwan
  • Taiwan Competes with the US in Kidney and LiverTransplant Survival Rates
  • Strategic Developments
  • Select Players
  • Terumo Corporation (Japan)
  • Ventracor Limited (Australia)
• B. Market Analytics
  • Table 55: Asia Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 56: Asia 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

5. Latin America

• A. Market Analysis
  • Current & Future Analysis
  • Brazil - A Major Transplant Market
• B. Market Analytics
  • Table 57: Latin America Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 58: Latin America 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

6. Rest of World

• A. Market Analysis
  • Current & Future Analysis
  • Kuwait - A Rapidly Emerging ‘Third World’Country in Organ Transplants
  • Strategic Development
• B. Market Analytics
  • Table 59: Rest of World Recent Past, Current & Future Market Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Independently Analyzed by Number of Procedures for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 60: Rest of World 10-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)